Once labeled the “disease of kings” because of its association with consuming rich foods and alcohol, gout has emerged as a royal pain to a growing number of people. A 2024 study showed the prevalence of the most common form of inflammatory arthritis jumping 22.5% between 1990 and 2020, to 55.8 million people worldwide, with 95.8 million projected by 2050. An aging population and rising rates of metabolic conditions like obesity, hypertension, and chronic kidney disease have fueled gout’s growing prevalence.

没有 北预计亚马逊州、帕拉州、阿马帕州和罗赖马州的降雨量最高，本周总降雨量可能超过200毫米。阿克里州、朗多尼亚州北部和托坎廷斯州的降雨则较为零星，强度也较小。该地区大部分地区最高气温预计在32摄氏度左右，帕拉州南部最高气温可能达到37摄氏度。

Just a few years ago, some food makers planned to wait around for GLP-1 users drop off the weight-loss medications and r…

世界农化网中文网报道：2026年5月31日，河南美利宝农业科技有限公司联合南京农业大学，组织一众权威专家，对南京农业大学在南京市浦口区桥林街道兰花塘（丽阳晨农业种植公司种植基地）实施的稻茬小麦喷施″黑能量增产肥″试验示范田开展现场实收测产。本次测产专家团队阵容权威，由南京农业大学姜东教授、周琴教授领衔，扬州大学、江苏省粮食作物现代产业技术协同创新中心、江苏省农业科学院、江苏里下河地区农业科学研究所、南京市农业技术推广站、南京市浦口区农业农村局等多家科研与农技推广单位专家共同参与，全程见证田间实收测产全过程，以标准化测产流程核验产品提质增产实效。

China’s new framework for advanced biomedical technologies could reshape how cell and gene therapies (CGTs) reach patients in one of the world’s most active biotech markets. State Council Order No. 818 took effect on May 1, 2026, and establishes China’s first national framework for the clinical research and translational application of new biomedical technologies, including cell therapies, gene therapies, gene editing, stem cell technologies, tissue engineering, and other emerging medical approaches.  

The biotech, which has a presence in Germany and Texas, has built a pipeline on preferentially expressed antigen in melanoma (PRAME). The cancer-testis antigen is broadly expressed in solid tumors, providing Immatics with chances to treat a range of diseases including cutaneous melanoma, uterine carcinoma and synovial sarcoma.

“Specialty crop growers are looking for practical, scalable automation technologies that can help them be more sustainable, efficient and profitable today, while also preparing for the future”, says Yamaha Agriculture President and CEO Nolan Paul.

Two years after emerging from bankruptcy, biomanufacturing specialist Amyris is not yet profitable, but is a “drasticall…

The Zug-based company said the DIAMOND-1 and DIAMOND-2 trials did not show a statistically meaningful improvement in best corrected visual acuity after 52 weeks of treatment compared with vehicle. The result is particularly damaging because visual acuity was the primary endpoint of the programme and the basis for a potential regulatory filing.